Zoetis Financial Statements
NYSE: ZTSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:03 PM ET · Delayed 15 min
Zoetis revenue and earnings
In fiscal 2025, Zoetis generated $9.47 billion in revenue, up 2.3% from fiscal 2024, its 10th consecutive year of revenue growth. Net income was $2.67 billion (+7.5% year over year), for a net margin of 28.2% versus a median of 26.2% in the prior 5 years. Gross margin was 71.8% (up from 70.6%).
Diluted earnings per share came in at $6.02, up from $5.47. Over the last 5 fiscal years, ZTS's revenue has grown at a 7.2% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Zoetis income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.47B | 9.26B | 8.54B | 8.08B | 7.78B | 6.67B | 6.26B | 5.83B | 5.31B | 4.89B |
| Revenue growth (YoY) | +2.28% | +8.33% | +5.74% | +3.91% | +16.49% | +6.63% | +7.47% | +9.76% | +8.57% | +2.58% |
| Cost of Revenue | 2.67B | 2.72B | 2.56B | 2.45B | 2.30B | 2.06B | 1.99B | 1.91B | 1.77B | 1.67B |
| Gross Profit | 6.80B | 6.54B | 5.98B | 5.63B | 5.47B | 4.62B | 4.27B | 3.91B | 3.53B | 3.22B |
| Research & Development | 698.00M | 686.00M | 614.00M | 539.00M | 508.00M | 463.00M | 457.00M | 432.00M | 382.00M | 376.00M |
| Selling, General & Admin | 2.38B | 2.32B | 2.15B | 2.01B | 2.00B | 1.73B | 1.64B | 1.48B | 1.33B | 1.36B |
| Interest Expense | 222.00M | 225.00M | 239.00M | 221.00M | 224.00M | 231.00M | 223.00M | 206.00M | 175.00M | 166.00M |
| Other Income (Expense) | 36.00M | 19.00M | 159.00M | -40.00M | -48.00M | -17.00M | 57.00M | 83.00M | -6.00M | 2.00M |
| Pretax Income | 3.36B | 3.13B | 2.94B | 2.66B | 2.49B | 2.00B | 1.80B | 1.69B | 1.52B | 1.23B |
| Income Tax | 687.00M | 637.00M | 596.00M | 545.00M | 454.00M | 360.00M | 301.00M | 266.00M | 663.00M | 409.00M |
| Net Income | 2.67B | 2.49B | 2.34B | 2.11B | 2.04B | 1.64B | 1.50B | 1.43B | 864.00M | 821.00M |
| Net Income growth (YoY) | +7.52% | +6.06% | +10.88% | +3.78% | +24.36% | +9.20% | +5.04% | +65.28% | +5.24% | +142.18% |
| EPS (Basic) | 6.03 | 5.47 | 5.08 | 4.51 | 4.29 | 3.44 | 3.14 | 2.96 | 1.76 | 1.66 |
| EPS (Diluted) | 6.02 | 5.47 | 5.07 | 4.49 | 4.27 | 3.42 | 3.11 | 2.93 | 1.75 | 1.65 |
| Shares Outstanding (Basic) | 443.44M | 454.20M | 461.17M | 468.89M | 474.35M | 475.50M | 478.13M | 483.06M | 489.92M | 495.71M |
| Shares Outstanding (Diluted) | 443.83M | 454.85M | 462.27M | 470.38M | 476.72M | 478.57M | 481.79M | 486.90M | 493.16M | 498.23M |
| Gross Margin | 71.84% | 70.62% | 70.03% | 69.63% | 70.38% | 69.18% | 68.18% | 67.19% | 66.55% | 65.92% |
| Net Margin | 28.23% | 26.86% | 27.43% | 26.16% | 26.20% | 24.54% | 23.96% | 24.52% | 16.28% | 16.80% |
This table shows 10 annual periods of Zoetis's income statement, from FY 2025 back to FY 2016, across 16 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow ZTS's reporting calendar. What is a income statement?